These results suggest that CCR2 blockade and Treg cell depletion may converge on shared or partially overlapping TME states, whereas VEGF blockade offers an orthogonal intervention and highlights potential for discovery of orthogonal cancer therapies through single-cell and spatial analyses of early TME responses to acute perturbation. The gene discussed is CCR2; the disease is cancer.